Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product

ClinicalTrials.gov ID: NCT02143843

Public ClinicalTrials.gov record NCT02143843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 12:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002

Study identification

NCT ID
NCT02143843
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
ForSight Vision5, Inc.
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

  • Bimatoprost Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 4, 2014
Primary completion
Dec 30, 2015
Completion
Jan 30, 2016
Last update posted
Feb 25, 2019

2014 – 2016

United States locations

U.S. sites
10
U.S. states
6
U.S. cities
10
Facility City State ZIP Site status
Sall Medical Research Center Artesia California 90701
Scripps Clinic Torrey Pines La Jolla California 92037
Eye Research Foundation Newport Beach California 92663
UC Davis Dept of Ophthalmology & Vision Science Sacramento California 95817
Coastal Research Associates Atlanta Georgia 30076
Clayton Eye Center Morrow Georgia 30260
Ophthalmology Consultants St Louis Missouri 63131
UNC Kittner Eye Center Chapel Hill North Carolina 27517
Apex Eye Madeira Ohio 45243
Ophthalmology Associates PC Fort Worth Texas 76102

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02143843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2019 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02143843 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →